Discount Agreement for Tiotropium + Olodaterol (01.06.2026 - 31.05.2028)
DAK-Gesundheit offers pharmaceutical companies the opportunity to enter into non-exclusive discount agreements for the active ingredient Tiotropium + Olodaterol. This allows all companies to join at any time under the same conditions.
CONTRACTING AUTHORITY
Name
DAK-Gesundheit
City
Hamburg
Country
DE
CLASSIFICATION
Procedure Type
Open Procedure
Contract Type
Supplies
Main CPV
33600000, Pharmaceutical products.
ADDITIONAL DETAILS
EU Funded
Yes
Suitable for SMEs
No
Electronic Submission
Required
Legal Basis
32014L0024
DEADLINES & TIMELINE
Submission Deadline
671 days remaining(LOT-0001)
Published